U.S. Infrastructure Stock News

NYSE:MC
NYSE:MCCapital Markets

3 U.S. M&A Advisor Stocks Built For Higher Rates

With the Fed funds rate still in the 3.50% to 3.75% range and banks keeping a tighter grip on lending, dealmaking is tilting toward buyers and advisors that can handle higher financing costs and focus on resilient cash flow. That shift is creating a fresh set of potential winners and laggards. This article profiles 3 U.S. Middle-Market M&A Advisors and Deal Services stocks that appear most exposed to these trends. The stocks covered below are just a starting sample, and the full screen...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Does Rusfertide Royalty Deal And Guidance Upgrade Change The Bull Case For Royalty Pharma (RPRX)?

Royalty Pharma recently agreed to pay Zealand Pharma US$100,000,000 for rights to future royalties and milestones tied to rusfertide, an experimental polycythemia vera treatment with an FDA decision previously guided for the third quarter of 2026. This deal adds a new late-stage, specialty-therapy royalty stream to Royalty Pharma’s portfolio, aligning with its focus on broadening exposure to innovative, high‑value medicines. We’ll now examine how acquiring future rusfertide royalties,...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Can Flywire (FLYW) Turn Niche Travel Partnerships Into Durable Payments-Market Advantage?

In August 2026, Travelling The Fairways International Ltd. announced it had chosen Flywire as its exclusive payments partner across its UK and Ireland golf tour operations, using Flywire’s platform to handle multi-currency, cross-border guest payments and improve transparency for international golfers. The deal highlights how Flywire’s sector-focused payments software can replace large general-purpose processors by cutting costs, simplifying tax reporting, and enhancing the experience for...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

Did Alleged Undisclosed Discounting Just Shift PROCEPT BioRobotics' (PRCT) Investment Narrative?

In recent months, multiple law firms have filed securities class action lawsuits against PROCEPT BioRobotics, alleging that undisclosed discounting programs inflated reported handpiece sales, revenues, and customer inventory levels between February 2024 and February 2026. The core allegation is that late-quarter bulk discounts pulled future demand forward and were not fully disclosed to investors, raising fresh questions about the quality and sustainability of the company’s reported growth...
NYSE:PK
NYSE:PKHotel and Resort REITs

Does Park Hotels & Resorts' (PK) New Loan And Upgrade Redefine Its Balance Sheet Playbook?

In late August and early September 2026, BMO Capital Markets upgraded Park Hotels & Resorts after the lodging REIT reported stronger-than-expected second-quarter results and arranged a US$700 million delayed draw loan facility to help manage upcoming debt maturities. The upgrade highlights how recent portfolio changes and balance sheet actions are reshaping perceptions of Park Hotels & Resorts’ future resilience and flexibility. Next, we’ll examine how the upgraded rating, backed by stronger...
NasdaqGS:ATAT
NasdaqGS:ATATHospitality

Is Atour Lifestyle Holdings (ATAT) Cheap On Strong 2026 Earnings And Revenue Guidance?

Why Atour Lifestyle Holdings stock is back in focus Atour Lifestyle Holdings (NasdaqGS:ATAT) is back on investors' radar after its latest quarterly report and new 2026 revenue guidance, which together offer fresh detail on the company's growth expectations. The company reported second quarter 2026 revenue of CNY 3,490.35 million and net income of CNY 547.72 million. It also issued guidance that points to a 30% increase in total net revenues for the full 2026 fiscal year compared with...
NasdaqGS:INDB
NasdaqGS:INDBBanks

3 Financial Stocks With Higher Rate Tailwinds Investors May Want To Research

With Fed Chair Kevin Warsh talking tougher on inflation and bond yields climbing, higher interest rates are reshaping the outlook for global large cap banks and diversified financials. That shift can change how these stocks earn money, reward patient investors or expose weak spots. This article looks at three stocks from the Global Large Cap Banks and Diversified Financials screener that appear positively exposed to the latest rate shock and explains why each one deserves a closer look...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

Atlanta Braves Holdings (BATR.K) Could Be 16% Below Fair Value On Rising MLB Team Valuations

Recent commentary points to rising valuations for rival Major League Baseball teams, which has drawn fresh attention to Atlanta Braves Holdings (BATR.K), the league’s only publicly traded franchise and a direct way to track this sector-wide repricing. At a share price of $50.21, Atlanta Braves Holdings has had a mixed short term run, with a 1-day share price return of 1.27% but a 7-day share price return that fell 5.21%. The year-to-date share price return of 25.97% and 5-year total...
NYSE:EVTC
NYSE:EVTCDiversified Financial

EVERTEC (EVTC) Draws Fresh Attention On Rising Earnings Views And An Undervalued Narrative

Recent coverage around EVERTEC (EVTC) has centered on a more positive earnings outlook and a favorable Zacks Rank, combined with valuation metrics that suggest the stock trades at a discount to its industry peers. Over the past year, EVERTEC’s share price has been volatile. A strong 90 day share price return of 29.2% contrasts with weaker recent moves, including a 1 day decline of 1.6% and a 30 day share price return down 4.2%. The 1 year total shareholder return is down 15.8%, and longer...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

Why Merit Medical Systems (MMSI) Is Getting Fresh Attention

Why this leadership change matters for Merit Medical Systems stock Merit Medical Systems (MMSI) drew fresh investor attention after announcing that Sheri Lewis will become Executive Vice President of Global Operations, with long-serving operations leader Mr. Peterson shifting into a Senior Advisor role. Merit Medical Systems shares trade at US$90.68, with a 30 day share price return of 6.67% and a 90 day share price return of 49.51%. Total shareholder return over three years is 41.91% and...
NYSE:BG
NYSE:BGFood

Is Bunge (BG) Using Sugar Mill Sales To Sharpen Its Core Agribusiness Focus?

Bunge Global has agreed to sell the Rio Vermelho and Nova Unialco sugarcane mills in São Paulo, Brazil, to COFCO International, with the deal still subject to customary closing conditions and regulatory approvals. This divestment reflects Bunge’s effort to refine its post-Viterra asset mix by exiting non-core sugar operations and reinforcing focus on its core agricultural and food supply businesses. We’ll now examine how exiting these Brazilian sugarcane mills could influence Bunge Global’s...
NYSE:PAGS
NYSE:PAGSDiversified Financial

Does PagSeguro’s Shift To an Independent Chair Reshape Its Governance Story for PagSeguro Digital (PAGS)?

PagSeguro Digital Ltd. reported that on August 21, 2026, founder and indirect controlling shareholder Luis Frias stepped down as Director and Chairman, with existing director Maria Judith de Brito assuming the Chair and Eduardo Alcaro reconfirmed as Vice-Chairman. The shift from founder-led board leadership to an independent Chair alters the company’s governance balance while Frias maintains control as majority owner. Now we’ll assess how Maria Judith de Brito’s appointment as Chair may...
NasdaqGS:GLBE
NasdaqGS:GLBEMultiline Retail

3 Stocks To Watch As Trade Shifts Reshape Sanmina, Global E Online And Flex

Global markets are being pulled in different directions as energy supply risks, softer central bank signals and fragile trade talks all hit headlines at once. That mix is creating sharp moves in globally exposed stocks, which can open interesting entry points or caution flags for long term investors. This article walks through three stocks from our Global Trade Exposed Equities screener that are closely tied to these developments and may warrant closer review by investors now. The three...
NasdaqGS:WMG
NasdaqGS:WMGEntertainment

Where Does Warner Music Group (WMG) Valuation Sit Following Its Q2 Earnings Beat?

What sparked the latest move in Warner Music Group stock Warner Music Group (WMG) recently reported Q2 results with revenue, earnings per share and EBITDA all coming in ahead of analyst expectations. The stock has climbed since the earnings release, drawing fresh attention from investors. At a share price of US$27.97, Warner Music Group has given investors a mixed ride, with a 30 day share price return of about 8% contrasting with a year to date decline of around 8% and a 1 year total...
NYSE:ARMK
NYSE:ARMKHospitality

Should Aramark’s (ARMK) Bigger College Footprint Reframe Its Long‑Term Campus Services Strategy?

In August 2026, Aramark announced it had expanded its collegiate footprint through new partnerships with Florida State University and Texas State University, integrating Sports + Entertainment and Collegiate Hospitality to upgrade game-day experiences, campus dining, and performance nutrition across venues and athlete facilities. This push deeper into higher education, where Aramark already serves about 300 colleges and universities and 47 NCAA athletic departments, underscores how scale and...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Is Intuitive Machines (LUNR) Still Below Fair Value After Its New IM 300 Contract?

Intuitive Machines (LUNR) recently announced a contract to build two IM 300 series spacecraft platforms for a new undisclosed customer. The award broadens its IM 300 customer base and highlights demand for modular, mission-configurable satellites. The new IM 300 contract comes after a sharp swing in Intuitive Machines’ share price. The stock is down 11.33% over the past week, even after a 19.29% gain over the past 30 days, while the 1-year total shareholder return of 69% points to strong...
NasdaqGS:LGIH
NasdaqGS:LGIHConsumer Durables

3 Housing Stocks Where Mortgage Rates Matter Most

With Treasury officials preparing to ramp up long bond buybacks and debate swirling around who really sets long term yields, housing linked stocks are suddenly back in focus. Big swings in mortgage costs can quickly change the story for builders, lenders and suppliers. This article walks through three stocks from the U.S. Housing & Mortgage Rate Sensitive Equities screener that appear especially exposed to this policy tug of war. The three stocks below are just a starting sample, since the...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Does Advancing First-in-Class Dry Eye and Pain Drugs Change The Bull Case For Bausch + Lomb (BLCO)?

In August 2026, Bausch + Lomb announced that two first-in-class eye health therapies, including a dual-action dry eye drop and the BL1332 TRPV1 antagonist for ocular pain, will advance to new clinical trials following encouraging early-stage results and a safety profile aligned with existing products. An interesting angle for investors is that the dual-action eye drop showed a meaningful benefit at an FDA-accepted Day 15 endpoint using over 50% less lifitegrast and reduced dosing frequency,...
NYSE:CALX
NYSE:CALXCommunications

Is Calix (CALX) Quietly Recasting Its Edge Through AI-Native Utilities Partnerships and New Marketing Leadership?

In August and September 2026, Calix, Inc. deepened its push into AI-powered broadband and utility markets, as Tantalus Systems announced a joint effort to bring fiber-enabled grid applications to cooperatives and municipal utilities, CoastConnect expanded its use of Calix’s agentic AI platform, and Calix appointed veteran technology marketer Juergen Lindner as chief marketing officer. Together, these moves highlight how Calix is coupling an AI-native platform with new utility partnerships...
NYSE:GRNT
NYSE:GRNTOil and Gas

Oil Price Shock Puts Granite Ridge Resources Stock And Energy Peers In Focus

Oil prices have jumped to multi month highs after strikes on Iranian assets and rising risk in the Strait of Hormuz, and that surge is rippling through global markets. Some energy related stocks in our Global Oil & Gas Producers screener are catching investor attention as a result. This article walks through 3 stocks that screens suggest are reacting positively to the news so you can decide whether they deserve a place on your watchlist. The three stocks covered below are only a small sample...
NYSE:NMAX
NYSE:NMAXMedia

Newsmax (NMAX) Could Be 44% Undervalued Following Its Streaming Growth Narrative

Newsmax (NMAX) stock has drawn attention after a recent move that left its one day return down 3.4%, even as the month return sits at 34.8% and the past 3 months at 21.4%. At a latest share price of $10.39, Newsmax has seen a sharp 30 day share price return of 34.8% and a year to date share price return of 31.9%, even though the 1 year total shareholder return is down 25.6%. This suggests that short term momentum has picked up while longer term holders have lagged. Scan beyond Newsmax and...
NYSE:TOL
NYSE:TOLConsumer Durables

Toll Brothers (TOL) Expands Luxury Communities, Is It Still Below Fair Value?

Toll Brothers (TOL) stock is in focus after a series of new luxury community announcements across Texas, Pennsylvania, Georgia, California, Nevada, and New York, highlighting active deployment of its homebuilding platform. The recent luxury community launches arrive after a soft patch in Toll Brothers share price, which is down 7.04% over the past week and 3.89% over the past month, although the 3-year total shareholder return of 81.35% and 5-year total shareholder return of 132.87% point to...
NYSE:PKG
NYSE:PKGPackaging

Packaging Corporation Of America (PKG) On Its Pullback And Whether The Value Case Still Holds

Packaging Corporation of America (PKG) has drawn investor attention after recent trading left the stock down about 7% over the past month, even as total return over the past 3 months remains slightly positive. At a share price of $229.12, Packaging Corporation of America has seen short-term momentum fade, with the 7-day share price return down 7.07% and the 30-day share price return down 6.80%. This is despite the year-to-date share price return of 8.53% and the 5-year total shareholder...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Pharmaceutical (RARE) After FDA Approval, Is The Gene Therapy Win Already Priced In?

Ultragenyx Pharmaceutical (RARE) stock is in focus after the U.S. Food and Drug Administration granted accelerated approval for GENGLYCOS, the company’s first gene therapy and a new treatment option for glycogen storage disease type Ia. At a share price of $25.81, Ultragenyx Pharmaceutical has a 90 day share price return of 15.17%, while the 1 year total shareholder return has declined 19.42%. Recent GENGLYCOS news appears to be improving momentum after several years of weaker overall...